Insider · CIK 0001742496
Gregory S. Moss
Files at AVR (Anteris Technologies Global Corp.), EVMN (Evommune, Inc.). First filing Jun 1, 2026, latest Jun 1, 2026.
In brief
Gregory S. Moss files SEC Form 4 as director and officer at EVMN (Evommune, Inc.), and also at AVR (Anteris Technologies Global Corp.). Since Jun 1, 2026, Gregory S. Moss has reported 0 open-market buys worth $0 and 1 open-market sell worth $325k, the latest filed on Jun 1, 2026.
A track record needs three past buys with six months of prices behind them; Gregory S. Moss has 0, so none is measured yet.
The newest scored trade: sold $325k of EVMN on May 28, 2026, filed Jun 1, 2026, scored 14 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 1 sell worth $325k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
EVMN: Evommune, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 14Weak | Evommune, Inc. | $325k 14,223 shares | -19% | +55% from low-26% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| May 28, 2026 | EVMN Evommune, Inc. | 14,223 0.04% of outstanding | $332k | May 28, 2026 | none |
Transactions
Every row this insider has filed, 12 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 7, 2026 | AVR Anteris Technologies Global Corp. | MOption exercise Common Stock | +17,580 | - | - | 17,580 | Jun 9, 2026 |
| Jun 7, 2026 | AVR Anteris Technologies Global Corp. | MOption exercise Restricted Stock Unitsderivative | -17,580 | $0.00 | $0 | 35,162 | Jun 9, 2026 |
| May 28, 2026 | EVMN Evommune, Inc. | MOption exercise Common Stock10b5-1 | +14,223 | $1.71 | $24k | 75,058 | Jun 1, 2026 |
| May 28, 2026 | EVMN Evommune, Inc. | SOpen-market sale Common Stock10b5-1 | -14,223 | $22.83 | $325k | 60,835 | Jun 1, 2026 |
| May 28, 2026 | EVMN Evommune, Inc. | MOption exercise Employee Stock Option (Right to Buy)derivative10b5-1 | -14,223 | $0.00 | $0 | 47,845 | Jun 1, 2026 |
| Apr 16, 2026 | EVMN Evommune, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +115,279 | $0.00 | $0 | 115,279 | Apr 17, 2026 |
| Dec 9, 2025 | EVMN Evommune, Inc. | FTax withholding Common Stock | -13,624 | $17.84 | $243k | 60,835 | Dec 11, 2025 |
| Dec 3, 2025 | AVR Anteris Technologies Global Corp. | AGrant or award Restricted Stock Unitsderivative | +52,742 | $0.00 | $0 | 52,742 | Dec 5, 2025 |
| Dec 3, 2025 | AVR Anteris Technologies Global Corp. | AGrant or award Restricted Stock Unitsderivative | +13,821 | $0.00 | $0 | 13,821 | Dec 5, 2025 |
| Nov 7, 2025 | EVMN Evommune, Inc. | CConversion Common Stockindirect: By Trust | +3,175 | - | - | 3,175 | Nov 12, 2025 |
| Nov 7, 2025 | EVMN Evommune, Inc. | CConversion Series B Preferred Stockderivativeindirect: By Trust | -25,000 | - | - | 0 | Nov 12, 2025 |
| Nov 5, 2025 | EVMN Evommune, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +293,496 | $0.00 | $0 | 293,496 | Nov 7, 2025 |
Questions about Gregory S. Moss
Answered from the filings on this page, as of the latest one.
Is Gregory S. Moss buying or selling?
In the last 12 months Gregory S. Moss reported 0 open-market buys worth $0 and 1 open-market sell worth $325k on SEC Form 4; the latest was sold $325k of EVMN on May 28, 2026. Grants, option exercises and tax withholding are not counted.
How did Gregory S. Moss's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Gregory S. Moss has 0.
Where does Gregory S. Moss file Form 4?
Gregory S. Moss has filed Form 4 at EVMN (Evommune, Inc.) as Chief Business & Legal Officer; AVR (Anteris Technologies Global Corp.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.